Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Treatment Outcome"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"CADTH Canadian Drug Expert Committee"
Search alternatives
:
outcome »
outcomes
Showing
1
-
18
of
18
Search:
'"Treatment Outcome"'
,
query time: 0.14s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Clinical review report: Brolucizumab (Beovu) (Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular degeneration (AMD)
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Treatment
Outcome
...
”
Read Now
2
CADTH Canadian Drug Expert Review Committee final recommendation: Adalimumab (Humira -- abbVie) : indication: ulcerative colitis
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Treatment
Outcome
...
”
Read Now
3
CADTH Canadian Drug Expert Review Committee final recommendation: Riociguat (Adempas - Bayer HealthCare Inc.) : indication: pulmonary arterial hypertension
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Treatment
Outcome
...
”
Read Now
4
Optimal use of minimally invasive glaucoma surgery: A health technology assessment : project protocol
Published 2018
CADTH
Subjects:
“
...
Treatment
Outcome
...
”
Read Now
5
CADTH Canadian drug expert committee recommendation: Burosumab (Crysvita -- Kyowa Kirin Limited) : indication : treatment of x-linked hypophosphatemia
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Treatment
Outcome
...
”
Read Now
6
Optimal use of minimally invasive glaucoma surgery: Recommendations
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Treatment
Outcome
...
”
Read Now
7
Optimal use of minimally invasive glaucoma surgery: Recommendations
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Treatment
Outcome
...
”
Read Now
8
CDEC final recommendation: Tiotropium bromide (Spiriva respimat -- Boehringer Ingelheim Canada Ltd.) : indication : chronic obstructive pulmonary disease
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Treatment
Outcome
...
”
Read Now
9
CDEC final recommendation: Tiotropium bromide (Spiriva respimat -- Boehringer Ingelheim Canada Ltd.) : indication : chronic obstructive pulmonary disease
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Treatment
Outcome
...
”
Read Now
10
Pharmacoeconomic review report: Savuconazole (Cresemba) (AVIR pharma inc.)
Published 2019
CADTH
Subjects:
“
...
Treatment
Outcome
...
”
Read Now
11
CADTH Canadian Drug Expert Committee recommendation: Ozenoxacin 1% cream (Ozanex -- Ferrer Internacional, S.A.) : indication: the topical treatment of impetigo in patients aged two...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Treatment
Outcome
...
”
Read Now
12
CADTH Canadian Drug Expert Committee recommendation: Ozenoxacin 1% cream (Ozanex -- Ferrer Internacional, S.A.) : indication: the topical treatment of impetigo in patients aged two...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Treatment
Outcome
...
”
Read Now
13
CADTH Canadian Drug Expert Committee recommendation: Cladribine (Mavenclad -- EMD Serono) : indication: relapsing-remitting multiple sclerosis
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Treatment
Outcome
...
”
Read Now
14
Pharmacoeconomic review report: Savuconazole (Cresemba) (AVIR pharma inc.)
Published 2019
CADTH
Subjects:
“
...
Treatment
Outcome
...
”
Read Now
15
CDEC final recommendation: Dolutegravir (Tivicay -- ViiV Healthcare ULC) : indication : HIV infection
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Treatment
Outcome
...
”
Read Now
16
CDEC final recommendation: Dolutegravir (Tivicay -- ViiV Healthcare ULC) : indication : HIV infection
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Treatment
Outcome
...
”
Read Now
17
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Lamivudine (Dovato -- ViiV healthcare ULC) : indication: as a complete regimen for the treatment of human immunode...
Published 2019
CADTH
Subjects:
“
...
Treatment
Outcome
...
”
Read Now
18
CADTH CDEC final recommendation: Empagliflozin (Jardiance -- Boehringer Ingelheim (Canada) Ltd.) : indication : Type 2 Diabetes mellitus
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Treatment
Outcome
...
”
Back
Narrow Search
Remove Filters
Clear Filter
Author: CADTH Canadian Drug Expert Committee
Year of Publication
From:
To:
Classification
610 - Medicine & health
13
330 - Economics
5
140 - Specific philosophical schools
2
800 - Literature & rhetoric
2
Language
English
18
Collection
National Center for Biotechnology Information
18
Author
CADTH Canadian Drug Expert Committee
Canadian Agency for Drugs and Technologies in Health
13
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22CADTH+Canadian+Drug+Expert+Committee%22&lookfor=%22Treatment+Outcome%22&type=Subject
Send by Email
×
Loading...